Quotes 5-day view Delayed Nasdaq
04/13/2021
04/14/2021
04/15/2021
04/16/2021
04/19/2021
Date
9.04(c)
8.68(c)
8.53(c)
8.2(c)
7.96(c)
Last
758 365
907 744
461 419
823 663
1 573 461
Volume
+0.67% -3.98% -1.73% -3.87% -2.93% Change
Sales 2021
76,4 M - -
Net income 2021
-17,7 M - -
Net Debt 2021
-
-
-
P/E ratio 2021
-28,9x
Yield 2021
-
Sales 2022
107 M - -
Net income 2022
-1,83 M - -
Net Debt 2022
-
-
-
P/E ratio 2022
-265x
Yield 2022
-
Capitalization
531 M 531 M -
Capi. / Sales 2021
6,95x
Capi. / Sales 2022
4,97x
Nbr of Employees
110
Free-Float
57,4%
Chromadex Corporation is an integrated nutraceutical company. The Company and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provides research and quality-control products and services to the natural products industry. The Company partners with universities and research institutions worldwide to discover, develop and create solutions to deliver the full potential of...
Notations Surperformance© of ChromaDex Corporation
Trading Rating : Investor Rating :
All news about CHROMADEX CORPORATION
News in other languages on CHROMADEX CORPORATION
- No features available -
Analyst Recommendations on CHROMADEX CORPORATION
Chart CHROMADEX CORPORATION
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends CHROMADEX CORPORATION
Short Term Mid-Term Long Term Trends Bearish Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
6
Average target price
16,67 $
Last Close Price
7,96 $
Spread / Highest target
151%
Spread / Average Target
109%
Spread / Lowest Target
50,8%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Nederland
Schweiz (DE)
United Kingdom
Report
